Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula (unspecified eye)
ICD-10 E09.3529 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula (unspecified eye).
E09.3529 refers to diabetes mellitus that is induced by drugs or chemicals, leading to significant complications such as proliferative diabetic retinopathy and traction retinal detachment affecting the macula of an unspecified eye. This condition arises when certain medications or toxic substances disrupt normal glucose metabolism, resulting in hyperglycemia and subsequent diabetes. Proliferative diabetic retinopathy is characterized by the growth of new blood vessels in the retina, which can lead to vision loss. The presence of traction retinal detachment indicates that these abnormal vessels are pulling on the retina, potentially causing severe visual impairment. Management of this condition requires careful monitoring of blood glucose levels, often through HbA1c testing, to assess long-term glucose control. Insulin therapy may be necessary to manage blood sugar levels effectively, especially in cases where oral hypoglycemics are insufficient. Regular ophthalmologic evaluations are crucial to monitor for retinal complications and to initiate timely interventions to preserve vision.
Detailed medication history, HbA1c levels, and treatment plans.
Management of patients with drug-induced diabetes and monitoring for complications.
Ensure accurate documentation of the type of diabetes and its management.
Visual acuity tests, retinal imaging results, and treatment plans for retinopathy.
Evaluation and treatment of diabetic retinopathy and retinal detachment.
Document the specific type of retinal detachment and any interventions performed.
Used for routine follow-up of diabetic retinopathy.
Document visual acuity, retinal findings, and treatment plans.
Ensure that the examination includes assessment of diabetic changes.
Several classes of medications, including corticosteroids, antipsychotics, and certain antihypertensives, can induce diabetes by affecting insulin secretion or action.
